7 results match your criteria: "Erasmus MC - University Center Rotterdam[Affiliation]"
Arthritis Care Res (Hoboken)
April 2024
Erasmus MC University Center Rotterdam, Rotterdam, The Netherlands.
Objective: Our objective was to evaluate the diagnostic performance of the EULAR, American College of Rheumatology (ACR), and National Institute for Health and Care Excellence (NICE) criteria by using clinical experts' diagnosis of clinically relevant knee osteoarthritis (OA) as the outcome of interest.
Methods: In a previous study, we recruited clinical experts to evaluate longitudinal (5-, 8-, and 10-year follow-up) clinical and radiographic data of symptomatic knees from the Cohort Hip and Cohort Knee (CHECK) study for the presence or absence of clinically relevant OA. In the current study, ACR, EULAR, and NICE criteria were applied to the same 5-, 8-, and 10-year follow-up data; then a knee was diagnosed with OA if fulfilling the criteria at one of the three time points (F1), two of the time points (F2), or at all three time points (F3).
Acta Orthop
September 2023
Department of Orthopedics and Sports Medicine, Erasmus MC University Medical Center, Rotterdam.
Rheumatology (Oxford)
August 2023
Department of General Practice, Erasmus MC University Center Rotterdam, Rotterdam, The Netherlands.
Objectives: To identify highly ranked features related to clinicians' diagnosis of clinically relevant knee OA.
Methods: General practitioners (GPs) and secondary care physicians (SPs) were recruited to evaluate 5-10 years follow-up clinical and radiographic data of knees from the CHECK cohort for the presence of clinically relevant OA. GPs and SPs were gathered in pairs; each pair consisted of one GP and one SP, and the paired clinicians independently evaluated the same subset of knees.
Semin Arthritis Rheum
August 2022
Department of General Practice, Erasmus MC University Center Rotterdam, Rotterdam, the Netherlands; Department of Orthopaedics & Sports Medicine, Erasmus MC University Center Rotterdam, Rotterdam, the Netherlands.
Objective: To internally and externally validate our diagnostic criteria of early stage knee osteoarthritis (OA) in the CHECK and OAI cohorts.
Design: We applied two previously developed diagnostic models to all knees in CHECK and OAI cohorts to calculate probabilities of early stage knee OA at baseline. Knees were categorized into three groups based on probability: 'no OA' (probability ≤ 30%), 'uncertain' (probability between 30% and 70%) and 'early stage OA' (probability ≥ 70%).
JAMA Netw Open
April 2022
Department of General Practice, Erasmus MC University Center Rotterdam, Rotterdam, the Netherlands.
Importance: Intra-articular (IA) glucocorticoid injection is widely used in patients with knee osteoarthritis (OA), but the safety of this technique is in question among physicians. Intramuscular (IM) glucocorticoid injection could be an alternative approach.
Objective: To investigate whether an IM glucocorticoid injection is noninferior to an IA glucocorticoid injection in reducing knee pain for patients with knee OA in primary care.
Arthritis Res Ther
August 2021
Department of General Practice, Erasmus MC University Center Rotterdam, Rotterdam, The Netherlands.
Background: Early diagnosis of knee osteoarthritis (OA) is important in managing this disease, but such an early diagnostic tool is still lacking in clinical practice. The purpose of this study was to develop diagnostic models for early stage knee OA based on the first 2-year clinical course after the patient's initial presentation in primary care and to identify whether these course factors had additive discriminative value over baseline factors.
Methods: We extracted eligible patients' clinical and radiographic data from the CHECK cohort and formed the first 2-year course factors according to the factors' changes over the 2 years.
Audiol Neurootol
February 2018
Department of Otorhinolaryngology/Audiology, Erasmus MC - University Center Rotterdam, Rotterdam, The Netherlands.
To contribute to a better understanding of the etiology in age-related hearing loss, we carried out a cross-sectional study of 3,315 participants (aged 52-99 years) in the Rotterdam Study, to analyze both low- and high-frequency hearing loss in men and women. Hearing thresholds with pure-tone audiometry were obtained, and other detailed information on a large number of possible determinants was collected. Hearing loss was associated with age, education, systolic blood pressure, diabetes mellitus, body mass index, smoking and alcohol consumption (inverse correlation).
View Article and Find Full Text PDF